Alexion Receives Orphan Drug Status For Dermatomyositis Treatment

The FDA has granted Orphan Drug status to Alexion Pharmaceuticals, Inc.’s humanized monoclonal antibody C5 Complement Inhibitor 5G1.1 for the treatment of patients with dermatomyositis.

Alexion is currently enrolling patients in a Phase Ib pilot clinical trial that is designed to gather clinical data regarding the safety profile and biological and clinical effects of 5G1.1 in this patient population.

The Orphan Drug designation provides Alexion with market exclusivity for seven years from the drug’s approval date.

“Dermatomyositis is a rare and severe inflammatory disorder, the rash and debilitating weakness of which we believe may be alleviated by 5G1.1,” said Leonard Bell, M.D., President and CEO of Alexion.

“We are enthused to work in collaboration with the FDA to as rapidly as possible attempt to provide an innovative therapy for this small, but underserved patient population.

We are continuing to aggressively pursue 5G1.1 in this and other potential orphan indications with the objective of providing relief to multiple underserved and previously unrecognised patient groups.”

Alexion is engaged in the discovery and development of therapeutic products aimed at treating patients with a wide array of severe disease states, including cardiovascular and autoimmune disorders, inflammation and cancer.

Alexion’s two lead product candidates are currently in eight clinical development programs.

5G1.1-SC, in collaboration with Procter & Gamble, is in a Phase IIb cardiopulmonary bypass efficacy trial and in two Phase II myocardial infarction efficacy trials.

Acquire Dragon Pharmaceutical Overseas

NPP 150 - Discount Price

Administration: Injection
Base Constituent: Nandrolone Phenylpropionate
Manufacturer: Dragon Pharma LLC
Pack: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $21.00

EQ 300 - Cheap Price

Administration: Injection
Basal Constituent: Boldenone Undecylenate
Produced by: Dragon Pharma
Unit: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Deca 300 - Bulk Price

Administration: Injection
Basic Substance: Nandrolone Decanoate
Made by: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (300 mg/mL)
Price: 10 x $45.00

Clenbuterol - Cheap Price

Administration: Oral
Base Substance: Clenbuterol Hydrochloride
Manufacturer: Dragon Pharma
Unit: 20 x 100 pastilles (40 mcg/pastille)
Price: 20 x $25

Trenbolone 200 - Bulk Price

Administration: Injection
Principal Constituent: Trenbolone Enanthate
Manufacturer: Dragon Pharma
Amount: 10 x 10 mL vial (200 mg/mL)
Price: 10 x $77.00

Deca 300 - Cheap Price

Administration: Injection
Base Component: Nandrolone Decanoate
Made by: Dragon Pharma LLC
Pack: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $37.00

Sustanon 350

Injectable Anabolic Steroid
Basic Substance: Testosterone Blend
Manufacturer: Dragon Pharmaceuticals
Amount: 1 X 10 ml (350 mg/ml)

Winstrol Tabs

Synthetic Anabolic Steroidal Agent
Basic Chemical Name: Stanozolol
Made by: Dragon Pharmaceutical
Package: 1 X 100 pastilles (50 mg/pill)

NPP 150 - Bulk Price

Administration: Injection
Active Chemical Name: Nandrolone Phenylpropionate
Made by: Dragon Pharmaceutical
Amount: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $30.00

Tritren 150

Injectable Anabolic Steroid
Basic Ingredient: Trenbolones Blend
Made by: Dragon Pharma
Pack: 1 X 10 ml (150 mg/ml)

1-Test Cyp 200

Injectable Steroid for Muscle Growth
Main Constituent: Dihydroboldenone Cypionate
Producer: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (200 mg/mL)

Propionat 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Chemical Name: Testosterone Propionate
Manufacturer: Dragon Pharmaceutical
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total